Resumen
The prevalence of allergic diseases is rising rapdly in the US and the world. While antibody drugs and corticosteroids can provide symptom relief, they cannot cure allergic diseases. Described herein is a novel approach to treating severe atopic allergic diseases-chimeric antigen receptor-engineered T cells-that target and eliminate the cells that produce the causative agent of all atopic allergic diseases, immunoglubulin E (IgE).
| Idioma original | English |
|---|---|
| Publicación | Delaware Journal of Public Health |
| Volumen | 9 |
| N.º | 3 |
| DOI | |
| Estado | Published - ago 2023 |
Huella
Profundice en los temas de investigación de 'CAR T Cells for Treating Severe Atopic Allergic Diseases'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver